Sign inJoin waitlistJoin the waitlist

Irtiza Sheikh

Associate Program Director · University of Texas M D Anderson Cancer Center

Credentials: · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Pediatric Hematology Oncology
University of Texas M D Anderson Cancer Center
2020–2022
Pediatrics
University of Texas Health Science Center at Houston
2017–2020
Texas Coll of Osteopathic Med
2013–2017

Research

Classical Hodgkin Lymphoma: From Past to Future-A Comprehensive Review of Pathophysiology and Therapeutic Advances
Review · International Journal of Molecular Sciences · 2023 · 45 citations
Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management
Children · 2021 · First of 3 authors · Corresponding · 29 citations
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective
Review · Cancers · 2022 · First of 6 authors · 12 citations

Priti Tewari
15 papers · 3 as a fellow
Branko Cuglievan
13 papers
Demetrios Petropoulos
12 papers
David McCall
11 papers
Cesar Nunez
10 papers
Sajad Khazal
10 papers
Amber Gibson
9 papers
DR
Dristhi Ragoonanan
9 papers · 4 as a fellow
Kris Mahadeo
9 papers
Michael Roth
9 papers
Miriam Garcia
9 papers
Jeremy Connors
8 papers

Clinical trials

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2026–2033
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Site PI · Recruiting · Phase 1, Phase 2
Nationwide Children's Hospital
2022–2027